When sourcing Pinealon for sale for laboratory applications, institutional researchers require verified sequence integrity, high purity, and comprehensive analytical documentation. Pinealon is a synthetic tripeptide (Glu-Asp-Arg) investigated primarily in preclinical models of neuronal stress, epigenetics, and cellular senescence. PX1 Research provides reference-grade Pinealon manufactured under strict quality standards for standardized in vitro and in vivo research protocols.
When sourcing Pinealon for sale for laboratory applications, institutional researchers require verified sequence integrity, high purity, and comprehensive analytical documentation. Pinealon is a synthetic tripeptide (Glu-Asp-Arg) investigated primarily in preclinical models of neuronal stress, epigenetics, and cellular senescence. PX1 Research provides reference-grade Pinealon manufactured under strict quality standards for standardized in vitro and in vivo research protocols.
Finding qualified Pinealon for sale requires selecting a manufacturer that adheres to stringent quality control criteria. Pinealon is a synthetic short peptide bioregulator comprising L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg, or EDR). In academic and preclinical settings, researchers evaluate Pinealon for its potential interactions with chromatin structure, transcriptional activity, and central nervous system (CNS) cellular stability.
To ensure reproducible experimental outcomes, research teams must source materials subjected to rigorous analytical validation. Substandard peptide batches containing residual trifluoroacetic acid (TFA), truncated synthesis sequences, or endotoxin contamination introduce confounding variables into enzymatic and transcriptomic assays. PX1 Research manufactures all compounds in GMP-compliant facilities within the United States, providing lot-specific third-party verification to support rigorous scientific inquiry across all research peptides.
Pinealon belongs to a distinct class of low-molecular-weight short peptide bioregulators. Composed of three amino acids—glutamic acid, aspartic acid, and arginine—the tripeptide possesses a molecular weight of approximately 389.36 g/mol. Its small steric footprint allows for potential direct interaction with cellular membranes and nuclear structures in vitro.
Preclinical data indicate that short peptide bioregulators like Pinealon can penetrate cell membranes without specialized transport systems. Once inside the nuclear compartment, these ultra-short peptides are hypothesized to bind specific histone proteins or targeted non-coding DNA sequences, influencing gene expression patterns without altering primary genomic sequences. Investigators exploring epigenetic regulation frequently incorporate the Pinealon 10mg peptide vial into experimental designs targeting age-related cellular modification.
Preclinical models evaluating oxidative stress in neuronal cultures demonstrate that Pinealon exposure correlates with shifts in endogenous antioxidant enzyme activity. In cell-based models of hypoxia and excitotoxicity, treatment with Glu-Asp-Arg has been observed to modulate superoxide dismutase (SOD) and glutathione peroxidase (GPx) expressions, mitigating oxidative damage to lipid membranes and mitochondrial structures.
In vitro assays using primary neuronal cell lines suggest that Pinealon attenuates reactive oxygen species (ROS) accumulation during induced stress events. Researchers measuring caspase activity and mitochondrial membrane potential indicate that the tripeptide may suppress pro-apoptotic signaling pathways under oxidative challenge. These findings make Pinealon a key subject of investigation in neuroprotection and cellular survival studies accessible through our research library hub.
Epigenetic regulation represents a primary focus of short peptide research. In vitro studies demonstrate that short peptide bioregulators can selectively bind to promoter regions of specific genes, modulating transcriptional machinery. For Pinealon, transcriptomic profiling in preclinical models reveals selective upregulation of genes involved in protein synthesis and cellular repair pathways.
Furthermore, research indicates that Pinealon may influence the expression of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), in isolated neural cell lines. By stabilizing mRNA transcripts associated with synaptic plasticity and structural integrity, Pinealon serves as a critical model peptide for investigating nuclear-peptide interaction kinetics.
Understanding where Pinealon fits within the broader landscape of peptide bioregulators requires comparing its target tissue specificity and primary molecular outcomes against related compounds. While all ultra-short peptides share basic mechanisms of chromatin interaction, their side-chain chemistry dictates target receptor affinity and transcriptomic profiles.
In comparative preclinical models, Epitalon (Ala-Glu-Asp-Gly) is predominantly evaluated for telomerase activation and neuroendocrine regulation in pineal tissue models. Conversely, Cortagen (Ala-Glu-Asp-Pro) exhibits pronounced specificity toward peripheral nerve regeneration and inflammatory cascade modulation. Pinealon (Glu-Asp-Arg), by contrast, displays strong tissue affinity for cortical neurons and cerebellar tissues, making it uniquely suited for investigations into central neuronal stress. Another related vessel-targeted peptide, Vesugen (Lys-Glu-Asp), focuses primarily on vascular endothelial cultures. Evaluating these compounds side-by-side allows laboratory researchers to map bioregulatory cascades across distinct physiological systems.
When acquiring a pinealon peptide for sale, establishing verification parameters is vital for scientific validity. Commercial synthetic peptides can vary significantly in purity, counter-ion content, and sterility depending on the synthesizer technology and purification protocols employed.
PX1 Research enforces strict compliance parameters for every production lot to guarantee research integrity:
• High-Performance Liquid Chromatography (HPLC): Confirms peptide purity levels exceeding 99%, ensuring the absence of truncated sequences or chemical impurities.
• Mass Spectrometry (MS): Verifies exact monoisotopic mass and primary amino acid sequence alignment for Glu-Asp-Arg.
• Endotoxin Testing (LAL Assay): Ensures bacterial endotoxin levels remain strictly below standard experimental limits (<0.01 EU/mg) for sensitive cell culture applications.
• ISO 17025 Laboratory Validation: Every batch undergoes testing in an independent, certified laboratory with lot-traceable documentation publicly accessible via our analytical peptide documentation portal.
Proper handling and reconstitution protocols are mandatory to maintain the structural stability of synthetic Pinealon during laboratory procedures. As a hydrophilic tripeptide, Pinealon readily dissolves in standard aqueous laboratory buffers.
For optimal stability, observe the following laboratory practices:
1. Reconstitution: Reconstitute lyophilized Pinealon powder using sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4). Avoid aggressive mechanical vortexing; gentle swiveling ensures complete dissolution.
2. Lyophilized Storage: Store desiccated lyophilized vials at -20°C for short-term preservation or -80°C for long-term storage up to 24 months.
3. Solution Storage: Once reconstituted, aliquot the solution into single-use microcentrifuge tubes to prevent freeze-thaw degradation. Store working aliquots at -20°C for up to 90 days or 4°C for short-term experimentation (under 7 days).
4. Contamination Prevention: Work within a certified laminar flow hood to maintain sterility during reconstitution and pipetting operations.
Designing experiments with Pinealon requires careful consideration of vehicle selection, concentration ranges, and assay timing. In vitro assays assessing cell viability, apoptosis, or gene expression typically utilize Pinealon working concentrations ranging from 10 nM to 1 µM, depending on the specific cell line (e.g., PC12, SH-SY5Y, or primary cortical neurons).
In rodent models of oxidative stress or ischemia, researchers administer target doses calculated per kilogram of body weight via standard parenteral routes (IP or SC) to evaluate systemic bioavailability and CNS penetrance. Maintaining accurate lot records and utilizing high-purity materials from verified suppliers ensures that experimental outcomes reflect true biological activity rather than background artifacts.
PX1 Research serves as a premier USA supplier of analytical-grade research peptides. Every order of Pinealon is fulfilled directly from domestic facilities located in California and Arizona, guaranteeing rapid turnaround times and optimal chain-of-custody control.
Orders placed Monday through Friday ship same-day, eliminating unnecessary transit delays that could compromise sensitive laboratory schedules. Institutions requiring high-volume supplies or custom synthesis solutions can utilize our bulk laboratory purchasing program to secure standardized batch production for long-term study protocols.
What is Pinealon for sale used for in research environments?
Pinealon for sale is supplied strictly for laboratory research use, including in vitro cellular assays and animal models. Researchers investigate Pinealon (Glu-Asp-Arg) to study its role in neuronal stress responses, epigenetic regulation, chromatin binding, and cellular aging mechanisms.
Where can I source Pinealon peptide for sale with verified purity?
High-purity Pinealon peptide for sale can be sourced directly from PX1 Research. All peptides are manufactured in US-based GMP-compliant facilities and undergo independent ISO 17025 third-party testing with lot-specific Certificate of Analysis (COA) documentation available.
What is the amino acid sequence of Pinealon?
Pinealon is a synthetic tripeptide consisting of three amino acids: L-glutamic acid, L-aspartic acid, and L-arginine. Its chemical sequence is abbreviated as Glu-Asp-Arg or EDR.
How should Pinealon be reconstituted for in vitro cellular assays?
For laboratory use, Pinealon should be reconstituted using sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4). Swirl gently to dissolve the powder; avoid aggressive agitation to prevent peptide shear.
What storage conditions maintain Pinealon stability in the laboratory?
Lyophilized Pinealon powder should be stored at -20°C or -80°C away from light and moisture. Reconstituted liquid aliquots should be frozen at -20°C and protected from repeated freeze-thaw cycles.
Does PX1 Research provide lot-specific Certificate of Analysis (COA) documents?
Yes. Every lot of Pinealon is supplied with a publicly accessible COA featuring high-performance liquid chromatography (HPLC) purity reports, mass spectrometry (MS) sequence verification, and endotoxin assay results.
How does Pinealon compare to Epitalon in gene-expression research models?
While both are short peptide bioregulators, Pinealon (Glu-Asp-Arg) targets neuronal cell structures and oxidative stress markers, whereas Epitalon (Ala-Glu-Asp-Gly) is studied primarily for pineal gland regulation and telomerase activity.
What are the endotoxin limits for PX1 Research peptides?
PX1 Research enforces strict quality thresholds, ensuring endotoxin levels remain below 0.01 EU/mg as measured by Limulus Amebocyte Lysate (LAL) testing, making them suitable for sensitive cell cultures.
What shipping timelines apply when ordering Pinealon peptide for sale?
All orders placed Monday through Friday before cut-off times ship same-day from PX1 Research dispatch centers in California and Arizona to minimize transit times for domestic research laboratories.
Can high-volume laboratories establish bulk ordering accounts with PX1 Research?
Yes. Academic institutions, biotechnology firms, and contract research organizations (CROs) can set up institutional accounts for bulk quantities and dedicated lot reservation through our wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.